IL69763A - Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof - Google Patents
Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereofInfo
- Publication number
- IL69763A IL69763A IL69763A IL6976383A IL69763A IL 69763 A IL69763 A IL 69763A IL 69763 A IL69763 A IL 69763A IL 6976383 A IL6976383 A IL 6976383A IL 69763 A IL69763 A IL 69763A
- Authority
- IL
- Israel
- Prior art keywords
- hydroxyvitamin
- epimer
- derivatives
- preparation
- certain novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/20—Free hydroxyl or mercaptan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL8075983A IL80759A (en) | 1982-09-20 | 1983-09-18 | 5,7-diene steroids useful as intermediates in the synthesis of 2k-hydroxyvitamin d2 and analogs thereof |
IL80759A IL80759A0 (en) | 1982-09-20 | 1986-11-25 | 5,7-diene steroids useful as intermediates in the synthesis of 25-hydroxy-vitamin d2 and analogs thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/420,191 US4448721A (en) | 1982-09-20 | 1982-09-20 | Hydroxyvitamin D2 compounds and process for preparing same |
Publications (2)
Publication Number | Publication Date |
---|---|
IL69763A0 IL69763A0 (en) | 1983-12-30 |
IL69763A true IL69763A (en) | 1987-01-30 |
Family
ID=23665448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL69763A IL69763A (en) | 1982-09-20 | 1983-09-18 | Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof |
Country Status (11)
Country | Link |
---|---|
US (1) | US4448721A (fr) |
EP (1) | EP0119251A1 (fr) |
JP (6) | JPS59501746A (fr) |
CA (1) | CA1283422C (fr) |
CH (1) | CH671222A5 (fr) |
DE (2) | DE3348322C2 (fr) |
FR (3) | FR2540869B1 (fr) |
GB (2) | GB2127023B (fr) |
IE (1) | IE56174B1 (fr) |
IL (1) | IL69763A (fr) |
WO (1) | WO1984001155A1 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5036061A (en) * | 1983-05-09 | 1991-07-30 | Deluca Hector F | Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds |
US4505906A (en) * | 1984-01-30 | 1985-03-19 | Wisconsin Alumni Research Foundation | Hydroxyvitamin D2 isomers |
US5120722A (en) * | 1984-02-08 | 1992-06-09 | Hoffmann-La Roche Inc. | Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia |
US4588716A (en) * | 1984-05-04 | 1986-05-13 | Wisconsin Alumni Research Foundation | Method for treating metabolic bone disease in mammals |
US4588528A (en) * | 1984-05-31 | 1986-05-13 | Wisconsin Alumni Research Foundation | 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same |
US4857518A (en) * | 1984-10-04 | 1989-08-15 | Wisconsin Alumni Research Foundation | Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same |
JPS62500301A (ja) * | 1984-10-04 | 1987-02-05 | ウイスコンシン アラムナイ リサ−チ フオンデ−シヨン | 24―ホモビタミンd誘導体 |
US5225579A (en) * | 1988-03-16 | 1993-07-06 | Hoxan Corporation | Method of manufacturing vitamin D2, Vitamin D3, activated type vitamin D2, activated type vitamin D3, and their derivatives |
US5030772A (en) * | 1990-02-14 | 1991-07-09 | Deluca Hector F | Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives |
IN171449B (fr) * | 1990-02-14 | 1992-10-17 | Wisconsin Alumni Res Found | |
US5260290A (en) * | 1990-02-14 | 1993-11-09 | Wisconsin Alumni Research Foundation | Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives |
US5063234A (en) * | 1990-05-25 | 1991-11-05 | Eli Lilly And Company | Method of inhibiting demineralization of bone |
US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
DE69233074T2 (de) * | 1991-01-08 | 2004-03-18 | Bone Care International Inc., Madison | Verfahren zur Herstellung von 1-alpha-24-dihydroxy-Vitamin D2 |
WO1993014763A1 (fr) * | 1992-01-29 | 1993-08-05 | Lunar Corporation | 1α-HYDROXY-24-EPI-VITAMINE D¿4? |
TW267161B (fr) * | 1992-11-20 | 1996-01-01 | Hoffmann La Roche | |
US5716946A (en) * | 1996-02-13 | 1998-02-10 | Wisconsin Alumni Research Foundation | Multiple sclerosis treatment |
US6479474B2 (en) | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
AU2002362443B2 (en) * | 2001-10-01 | 2008-05-15 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
US20060003950A1 (en) * | 2004-06-30 | 2006-01-05 | Bone Care International, Inc. | Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
US7947682B2 (en) * | 2004-12-29 | 2011-05-24 | University Of Southern California | Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents |
JP5869745B2 (ja) | 2006-02-03 | 2016-02-24 | プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー | 25−ヒドロキシビタミンd2及び25−ヒドロキシビタミンd3によるビタミンd不足及び欠乏の治療 |
WO2007120972A2 (fr) * | 2006-02-10 | 2007-10-25 | University Of Virginia Patent Foundation | Procede permettant de traiter l'anemie a hematies falciformes |
US8188063B2 (en) * | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
EP3659608A1 (fr) | 2006-06-21 | 2020-06-03 | Opko Ireland Global Holdings, Ltd. | Thérapie faisant appel à un agent de répétition de la vitamine d et agent de remplacement hormonal de la vitamine d |
CN104257667B (zh) | 2007-04-25 | 2019-06-04 | 欧普科Ip 控股Ii 有限公司 | 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物 |
ES2956794T3 (es) | 2007-04-25 | 2023-12-28 | Eirgen Pharma Ltd | Liberación controlada de 25-hidroxivitamina D |
US8058259B2 (en) * | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
CN102046812A (zh) | 2008-04-02 | 2011-05-04 | 赛特克罗公司 | 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒 |
US9212136B2 (en) * | 2008-07-22 | 2015-12-15 | Azad Pharmaceuticals Ingredients Ag | Methods for producing paricalcitol |
SG173119A1 (en) * | 2009-01-27 | 2011-08-29 | Berg Biosystems Llc | Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
BR112012003372A2 (pt) | 2009-08-14 | 2019-09-24 | Berg Biosystems Llc | vitamina d3 e análogos da mesma para o tratamento de alopecia. |
KR102125424B1 (ko) | 2010-03-29 | 2020-06-22 | 사이토크로마 인코포레이티드 | 부갑상선 수준을 낮추기 위한 방법 및 조성물 |
CA2698160C (fr) * | 2010-03-30 | 2017-07-25 | Alphora Research Inc. | Doxercalciferol stabilise et procede pour le produire |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
EP3003497B1 (fr) | 2013-05-29 | 2024-02-14 | BPGbio, Inc. | Prévention ou atténuation de l'alopécie induite par la chimiothérapie au moyen de vitamine d |
SG10201911274TA (en) | 2014-08-07 | 2020-02-27 | Opko Ireland Global Holdings Ltd | Adjunctive therapy with 25-hydroxyvitamin d |
BR112018069727A2 (pt) | 2016-03-28 | 2019-02-05 | Opko Ireland Global Holdings Ltd | métodos de tratamento com vitamina d |
CN115947678B (zh) * | 2023-03-10 | 2024-01-16 | 成都诺森医学检验有限公司 | 稳定同位素2h(d)标记25-羟基维生素d2的合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2012069B1 (fr) * | 1968-07-01 | 1973-06-08 | Wisconsin Alumni Res Found | |
US3880894A (en) * | 1974-05-24 | 1975-04-29 | Wisconsin Alumni Res Found | 1,25-Dihydroxyergocalciferol |
US4105660A (en) * | 1977-06-29 | 1978-08-08 | Merck & Co., Inc. | Preparation of 3β-hydroxy-27-norcholest-5,7-dien-25-one |
US4145346A (en) * | 1977-10-03 | 1979-03-20 | Merck & Co., Inc. | Preparation of 3β-hydroxy-27-norcholest-5-ene-25-one and intermediates thereof |
US4229358A (en) * | 1978-07-26 | 1980-10-21 | Wisconsin Alumni Research Foundation | Fluorovitamin D compounds and processes for their preparation |
US4188345A (en) * | 1978-07-26 | 1980-02-12 | Wisconsin Alumni Research Foundation | Fluorovitamin D compounds and processes for their preparation |
US4265822A (en) * | 1979-09-10 | 1981-05-05 | Wisconsin Alumni Research Foundation | Process for preparing 1-hydroxylated vitamin D compounds from 5,6-trans-vitamin D compounds |
DE3048698A1 (de) * | 1980-12-23 | 1982-07-15 | Wisconsin Alumni Research Foundation, 53707 Madison, Wis. | Verfahren zur herstellung einer 1(alpha)-hydroxylierten vitamin-d-verbindung, ausgehend von einer 5,6-trans-vitamin-d-verbindung |
-
1982
- 1982-09-20 US US06/420,191 patent/US4448721A/en not_active Expired - Lifetime
-
1983
- 1983-09-12 DE DE3348322A patent/DE3348322C2/de not_active Expired - Lifetime
- 1983-09-12 WO PCT/US1983/001393 patent/WO1984001155A1/fr active Application Filing
- 1983-09-12 JP JP58503103A patent/JPS59501746A/ja active Granted
- 1983-09-12 EP EP83903074A patent/EP0119251A1/fr not_active Withdrawn
- 1983-09-12 CH CH2538/84A patent/CH671222A5/de not_active IP Right Cessation
- 1983-09-12 DE DE19833390212 patent/DE3390212T1/de active Granted
- 1983-09-18 IL IL69763A patent/IL69763A/xx not_active IP Right Cessation
- 1983-09-19 CA CA000436979A patent/CA1283422C/fr not_active Expired - Lifetime
- 1983-09-20 GB GB08325131A patent/GB2127023B/en not_active Expired
- 1983-09-20 FR FR838314942A patent/FR2540869B1/fr not_active Expired
- 1983-09-20 IE IE2203/83A patent/IE56174B1/en not_active IP Right Cessation
-
1984
- 1984-07-09 GB GB08417477A patent/GB2142922B/en not_active Expired
- 1984-10-15 FR FR8415789A patent/FR2555172B1/fr not_active Expired
- 1984-10-15 FR FR848415790A patent/FR2555173B1/fr not_active Expired
-
1989
- 1989-12-27 JP JP1336822A patent/JPH02209888A/ja active Granted
- 1989-12-27 JP JP1336825A patent/JPH0610187B2/ja not_active Expired - Lifetime
- 1989-12-27 JP JP1336821A patent/JPH02209887A/ja active Granted
- 1989-12-27 JP JP1336823A patent/JPH02209862A/ja active Granted
- 1989-12-27 JP JP1336824A patent/JPH02209863A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL69763A (en) | Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof | |
DE3372476D1 (en) | Preparation of p-nitrosodiphenylamine | |
GB2159055B (en) | Pharmaceutical compositions of 3,7,11,15-tetra-methylhexadec-1-en-3-ol | |
IL68537A (en) | Preparation of 26,26,26,27,27,27,-hexafluoro-1,25-dihydroxy-cholesterol | |
PT81502A (en) | Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same | |
DE3367931D1 (en) | Preparation of 1,4-diketopyrrolo-(3,4-c)-pyrroles | |
PT77694B (en) | Process for the preparation of mevalono lactone analogs and their derivatives and pharmaceutical compositions containing them | |
DE3377212D1 (en) | New substituted derivatives of 2,5-diamino 1,4-diazole, preparation methods thereof and pharmaceutical compositions containing them | |
IL60905A (en) | Preparation of 1-hydroxylated vitamin d compounds from 5,6-trans-vitamin d compounds | |
IL69996A0 (en) | Substituted bis-phenoxy compounds and their thio analogs and pharmaceutical compositions containing them | |
GB8300598D0 (en) | Preparation of 3,3'/3,4' diaminobenzophenones | |
IL69322A0 (en) | Preparation of substituted thiadiazolylacetamides | |
IL74264A (en) | Preparation of calciferol derivatives,certain such novel compounds and pharmaceutical compositions containing them | |
GB8317345D0 (en) | Preparation of arylethylamines | |
GB8321666D0 (en) | Preparation of materials | |
ZA83923B (en) | Use of cholecalciferol derivatives | |
GB8322800D0 (en) | Preparation of 1,2,4,5-tetraalkylbenzenes | |
IL69848A0 (en) | 15-cycloaliphatic derivatives of 11,14-didehydrocarboprostacyclins,their preparation and pharmaceutical compositions containing them | |
DE3360784D1 (en) | Preparation of nitro-olefins | |
GB2120656B (en) | Preparation of thio-bis-phenols | |
IL69385A0 (en) | Preparation of 1-azolyl-3,3-dimethyl-1-phenoxybutan-2-ols | |
IL65464A0 (en) | Haloalkylthio-1,3-dihydro 2,4-dioxo-quinazolines,a method of their preparation and microbicidal compositions containing them | |
GB8300977D0 (en) | Preparation of substituted chloroacentanilides | |
AU553454B2 (en) | Preparation of 3,3:-diaminodiphenyl sulfones | |
AU7777681A (en) | 3-amino-2-alkenylimidates, 5 analogs and preparation of 2-aminopyrimidines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |